Aurora Cannabis Inc. (ACB) vs Standard BioTools Inc. (LAB)
A side-by-side comparison of Aurora Cannabis Inc. and Standard BioTools Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACB
Aurora Cannabis Inc.
$4.59HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
LAB
Standard BioTools Inc.
$0.72HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ACB vs LAB
growth of $100 · dividends reinvested · last 10yACB -97.3% (-30.2%/yr)LAB -90.5% (-20.9%/yr)LAB compounded faster over this window
ACB LAB
ACB vs LAB: by the numbers
- •ACB is the larger company ($284M vs $283M market cap).
- •Both run net losses; ACB's is the smaller (-38.13% vs -103.29% net margin).
- •ACB grew revenue faster over the past five years (1.68% vs -10.62% CAGR).
Metrics side by side
Valuation
| Metric | ACB | LAB |
|---|---|---|
| P/S ratio | 1.36 | 3.34 |
| P/B ratio | 0.77 | 0.52 |
Profitability
| Metric | ACB | LAB |
|---|---|---|
| Gross margin | 42.62% | 49.14% |
| Operating margin | -14.55% | -109.34% |
| Net margin | -38.13% | -103.29% |
| ROE | -21.41% | -16.18% |
| ROIC | -15.69% | -14.06% |
Growth (annualized)
| Metric | ACB | LAB |
|---|---|---|
| Revenue CAGR (5Y) | 1.68% | -10.62% |
| Total return CAGR (5Y) | -42.83% | -32.98% |
Frequently asked
- Which has grown faster, ACB or LAB?
- Over the past five years, ACB grew revenue faster — ACB at a 1.68% CAGR versus LAB at -10.62%.
- How have ACB and LAB total returns compared?
- Over the past 10 years, ACB delivered -30.23% and LAB delivered -20.93% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.